DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 4.66% to $7.46 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.46% to 51,947.25 and the NASDAQ Composite Index falling 0.64% to 24,975.82.
This was the stock's third consecutive day of losses.
Novavax Inc. closed 37.68% below its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 1.59% to $263.40, Pfizer Inc. $(PFE)$ fell 0.16% to $24.54, and Merck & Co. Inc. $(MRK)$ rose 0.45% to $131.07.
Trading volume (3.2 M) remained 1.3 million below its 50-day average volume of 4.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 24, 2026 17:29 ET (21:29 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.